H.R. 9321 · 117th Congress
Independent Drug Value Assessment Act
- Stage
- In committee
- Sponsor
- Jackie Speier
- Introduced
- 2022-11-16
- Latest action
- 2022-11-17 · Referred to the Subcommittee on Health.
Summary
Independent Drug Value Assessment Act
This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system).